Effect of continuous subcutaneous Treprostinil therapy on the pharmacodynamics and pharmacokinetics of warfarinWADE, Michael; HUNT, Thomas L; LAI, Allen A et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 908-915, issn 0160-2446, 8 p.Article

Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertensionWILLERS, Elisabeth D; NEWMAN, John H; HUMBERT, Marc et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 7, pp 798-802, issn 1073-449X, 5 p.Article

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension : A prospective, multicenter, open-label, 12-week trialTAPSON, Victor F; GOMBERG-MAITLAND, Mardi; MCLAUGHLIN, Vallerie V et al.Chest. 2006, Vol 129, Num 3, pp 683-688, issn 0012-3692, 6 p.Article

Pulmonary hypertension and cor pulmonale in COPDLEE-CHIONG, Teofilo L; MATTHAY, Richard A.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 263-272, issn 1069-3424, 10 p.Article

Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in childrenHISLOP, A. A; MOLEDINA, S; FOSTER, H et al.The European respiratory journal. 2011, Vol 38, Num 1, pp 70-77, issn 0903-1936, 8 p.Article

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinilBARST, R. J; GALIE, N; NAEIJE, R et al.The European respiratory journal. 2006, Vol 28, Num 6, pp 1195-1203, issn 0903-1936, 9 p.Article

Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patternsBURG, Elyssa D; PLATOSHYN, Oleksandr; TSIGELNY, Igor F et al.American journal of physiology. Cell physiology. 2010, Vol 67, Num 3, issn 0363-6143, C496-C509Article

Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: A preliminary studyJURASZ, Paul; NG, Douglas; GRANTON, John T et al.Thrombosis research. 2010, Vol 125, Num 1, pp 53-60, issn 0049-3848, 8 p.Article

Impact of pulmonary vascular stiffness and vasodilator treatment in pediatric pulmonary hypertension: 21 patient-specific fluid―structure interaction studiesZHENBI SU; HUNTER, Kendall S; SHANDAS, Robin et al.Computer methods and programs in biomedicine (Print). 2012, Vol 108, Num 2, pp 617-628, issn 0169-2607, 12 p.Article

Pulmonary arterial hypertension associated with fenfluramine exposure : report of 109 cases. CommentaryWEIR, E. K; OBREZTCHIKOVA, M; HERVE, P et al.The European respiratory journal. 2008, Vol 31, Num 2, issn 0903-1936, 232-235, 343-348 [10 p.]Article

Medical therapy for pulmonary arterial hypertension: ACCP Evidence-based clinical practice guidelinesBADESCH, David B; ABMAN, Steve H; AHEARN, Gregory S et al.Chest. 2004, Vol 126, Num 1, pp S35-S62, issn 0012-3692, SUPArticle

Pulmonary Arterial HypertensionHIGHLAND, Kristin B.The American journal of the medical sciences. 2008, Vol 335, Num 1, pp 40-45, issn 0002-9629, 6 p.Article

EFFECTS OF VERAPAMIL AND ASPIRIN ON EXPERIMENTAL CHRONIC HYPOXIC PULMONARY HYPERTENSION AND RIGHT VENTRICULAR HYPERTROPHY IN RATSKENTERA D; SUSIC D; ZDRAVKOVIC M et al.1979; RESPIRATION; CHE; DA. 1979; VOL. 37; NO 4; PP. 192-196; BIBL. 9 REF.Article

Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAsLEE, Jason E; YANG, Yang-Ming; HUIJUAN YUAN et al.American journal of physiology. Cell physiology. 2013, Vol 73, Num 2, issn 0363-6143, C312-C323Article

PAR-2 Inhibition Reverses Experimental Pulmonary HypertensionKWAPISZEWSKA, Grazyna; MARKART, Philipp; SEEGER, Werner et al.Circulation research. 2012, Vol 110, Num 9, pp 1179-1191, issn 0009-7330, 13 p.Article

Peroxisome Proliferator-Activated Receptor-γ Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B ReceptorYAHAN LIU; XIAO YU TIAN; GUANGMEI MAO et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 60, Num 6, pp 1471-1478, issn 0194-911X, 8 p.Article

Endothelin-1/endothelin-3 ratio: A potential prognostic factor of Pulmonary arterial hypertensionMONTANI, David; SOUZA, Rogerio; BINKERT, Christoph et al.Chest. 2007, Vol 131, Num 1, pp 101-108, issn 0012-3692, 8 p.Article

Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertensionBULL, Todd M; COLDREN, Christopher D; MOORE, Mark et al.American journal of respiratory and critical care medicine. 2004, Vol 170, Num 8, pp 911-919, issn 1073-449X, 9 p.Article

Inflammation in pulmonary arterial hypertensionDORFMÜLLER, P; PERROS, F; BALABANIAN, K et al.The European respiratory journal. 2003, Vol 22, Num 2, pp 358-363, issn 0903-1936, 6 p.Article

Eisenmenger Syndrome: Not Always InoperableHUANG, Jing-Bin; JIAN LIANG; ZHOU, Li-Yan et al.Respiratory care. 2012, Vol 57, Num 9, pp 1488-1495, issn 0020-1324, 8 p.Article

Plumbagin reverses proliferation and resistance to apoptosis in experimental PAHCOURBOULIN, Audrey; BARRIER, Marjorie; PROVENCHER, Steeve et al.The European respiratory journal. 2012, Vol 40, Num 3, pp 618-629, issn 0903-1936, 12 p.Article

Prognostic Significance of Sympathetic Nervous System Activation in Pulmonary Arterial HypertensionCIARKA, Agnieszka; DOAN, Vi; VELEZ-ROA, Sonia et al.American journal of respiratory and critical care medicine. 2010, Vol 181, Num 11, pp 1269-1275, issn 1073-449X, 7 p.Article

Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertensionPULIDO, T; SANDOVAL, J; ROQUET, I et al.European journal of clinical investigation. Supplement. 2009, Vol 39, Num 2, pp 14-18, issn 0960-135X, 5 p.Article

Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertensionCIARKA, Agnieszka; VACHIERY, Jean-Luc; HOUSSIERE, Anne et al.Chest. 2007, Vol 131, Num 6, pp 1831-1837, issn 0012-3692, 7 p.Article

Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertensionMORTY, Rory E; NEJMAN, Bozena; SCHERMULY, Ralph T et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 5, pp 1072-1078, issn 1079-5642, 7 p.Article